Merck (MRK) Equity Ratio (2009 - 2026)

Merck (MRK) has 18 years of Equity Ratio data on file, last reported at 0.36 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.36, down 15.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.36 (down 15.2% YoY), and the FY2025 annual result was 0.38, down 2.83% from the prior year.
• Equity Ratio retreated to 0.36 in Q1 2026 per MRK's latest filing, from 0.38 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.44 in Q1 2023 and troughed at 0.35 in Q4 2023.
• A 5-year average of 0.39 and a median of 0.39 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2023: Equity Ratio increased 28.99% in 2022, then slipped 16.38% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.42 in 2022, then fell by 16.38% to 0.35 in 2023, then gained by 12.24% to 0.4 in 2024, then declined by 2.83% to 0.38 in 2025, then retreated by 7.34% to 0.36 in 2026.
• Business Quant data shows MRK's Equity Ratio at 0.36 in Q1 2026, 0.38 in Q4 2025, and 0.4 in Q3 2025.